| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 2
DESIGN AND DEVELOPMENT OF ENTERIC AND COMPRESSION COATED COLONIC TABLETS: AN IN VITRO EVALUATION
Department of Pharmaceutics and Pharmaceutical Technology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
Viewed :
17720
-
Downloaded :
6313
Colon targeted delivery of metronidazole, which immediately releases the drug as soon as the drug delivery system reaches the colon was formulated for treatment of Crohn’s Disease. To prepare colonic tablets the core tablets of metronidazole were first compression coated with time dependent polymer, PEO/ HPMC, and then with pH dependent polymer, Eudragit® S100. Swelling study concluded that PEO showed higher swelling capacity compared to HPMC. Metronidazole core tablets compression coated with 250 mg PEO (Polyox® 1105) and enteric coated with 6% w/w of Eudragit® S100 showed 100% drug release within 1 h after the delivery system reaches the colon.
Keywords :
CROHN’S DISEASE, PEO, HPMC, SWELLING STUDY